AZD2281 Plus Carboplatin to Treat Breast and Ovarian Cancer
Read time: 1 mins
Last updated:30th Sep 2011
To determine the optimum doses of AZD2281 and carboplatin that can safely be used in patients with breast and ovarian cancer. To evaluate the response of the tumor to the drug combination and determine the side effects of the treatment.
|Study start date||2011-09-30|